Hypercoagulability and high residual platelet reactivity in ACS patients on dual antiplatelet therapy

被引:0
作者
Paniccia, R. [1 ]
Marcucci, R. [1 ]
Attanasio, M. [1 ]
Grifoni, E. [1 ]
Priora, R. [2 ]
Ahmed, Y. [1 ]
Giglioli, C. [2 ]
Abbate, R. [3 ]
Gensini, G. F. [3 ,4 ]
机构
[1] Univ Florence, Expt & Clin Med, Florence, Italy
[2] Careggi Hosp, Florence, Italy
[3] Univ Florence, Florence, Italy
[4] Don Carlo Gnocchi Fdn, Florence, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PO076-TUE
引用
收藏
页码:535 / 536
页数:2
相关论文
共 50 条
  • [41] Platelet reactivity in patients with coronary artery disease undergoing dual antiplatelet therapy with aspirin and clopidogrel
    Nguyen, My H. T.
    Nguyen, Nghia T.
    BIOMEDICAL RESEARCH AND THERAPY, 2024, 11 (05): : 6426 - 6433
  • [42] Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor
    Barbieri, Lucia
    Verdoia, Monica
    Nardin, Matteo
    Marino, Paolo
    Suryapranata, Harry
    De Luca, Giuseppe
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B82 - B82
  • [43] Red blood cell transfusions increase platelet reactivity in patients treated with dual antiplatelet therapy
    Quillot, M.
    Lhermusier, T.
    Payrastre, B.
    Garcia, C.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1223 - 1223
  • [44] Prognostic implication of high residual platelet reactivity and antiplatelet therapy in patients undergoing percutaneous coronary intervention for chronic total occlusion
    De Gregorio, M. G.
    Morini, S.
    Berteotti, M.
    Bernardini, A.
    Vergara, R.
    Migliorini, A.
    Carrabba, N.
    Gori, A. M.
    Marcucci, R.
    Valenti, R.
    EUROPEAN HEART JOURNAL, 2018, 39 : 136 - 137
  • [45] Altered ultralarge Von Willebrand factor levels and ADAMTS-13 activity affect residual platelet reactivity in high risk vascular patients on dual antiplatelet therapy
    Marcucci, R.
    Cesari, F.
    Cinotti, S.
    Gori, A. M.
    Paniccia, R.
    Gensini, G. F.
    Abbate, R.
    EUROPEAN HEART JOURNAL, 2007, 28 : 668 - 669
  • [46] Antiaggregant therapy and reduction of high residual platelet reactivity
    Mazur, N. A.
    Lomonosova, A. A.
    Zolozova, E. A.
    Sayutina, E. A.
    Chigineva, V. V.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2012, (04): : 74 - 78
  • [47] Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity
    Verdoia, Monica
    Pergolini, Patrizia
    Rolla, Roberta
    Barbieri, Lucia
    Schaffer, Alon
    Marino, Paolo
    Bellomo, Giorgio
    Suryapranata, Harry
    De Luca, Giuseppe
    ANGIOLOGY, 2018, 69 (06) : 490 - 496
  • [48] Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy
    Nishi, Hidehisa
    Nakahara, Ichiro
    Matsumoto, Shoji
    Hashimoto, Tetsuya
    Ohta, Tsuyoshi
    Sadamasa, Nobutake
    Ishibashi, Ryota
    Gomi, Masanori
    Saka, Makoto
    Miyata, Haruka
    Watanabe, Sadayoshi
    Okata, Takuya
    Sonoda, Kazutaka
    Kouge, Junpei
    Ishii, Akira
    Nagata, Izumi
    Kira, Jun-ichi
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2016, 8 (09) : 949 - 953
  • [49] Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome
    Scudiero, F.
    Valenti, R.
    Marcucci, R.
    Sanna, G. D.
    Gori, A. M.
    Migliorini, A.
    Vitale, R.
    Giusti, B.
    De Vito, E.
    Corda, G.
    Paniccia, R.
    Parodi, G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 4007 - 4007
  • [50] Comparison of Three Tests to Distinguish Platelet Reactivity in Patients with Renal Impairment during Dual Antiplatelet Therapy
    Guo, Long Zhe
    Kim, Moo Hyun
    Kim, Tae Hyung
    Park, Jong Seong
    Jin, Enze
    Shim, Chang Heon
    Choi, Sun Young
    Serebruany, Victor L.
    NEPHRON, 2016, 132 (03) : 191 - 197